Allena Pharmaceuticals

+$0.0085 (+7.46%) Today
+$0.0014 (+1.14%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNA and other ETFs, options, and stocks.

About ALNA

Allena Pharmaceuticals, Inc. engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease.

CEO
Louis Brenner
Employees
22
Headquarters
Newton, Massachusetts
Founded
2011

ALNA Key Statistics

Market cap
13.68M
Price-Earnings ratio
—
Dividend yield
—
Average volume
10.68M
High today
$0.125
Low today
$0.111
Open price
$0.1146
Volume
6.22M
52 Week high
$1.45
52 Week low
$0.0683

ALNA Earnings

-$0.24
-$0.11
$0.03
$0.16
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.13 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure